FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,676 | -43.9% | 42,300 | +25.9% | 0.00% | -50.0% |
| Q2 2023 | $159,936 | +55.9% | 33,600 | +86.7% | 0.00% | +100.0% |
| Q1 2023 | $102,600 | -18.0% | 18,000 | +45.2% | 0.00% | 0.0% |
| Q4 2022 | $125,116 | -61.6% | 12,400 | +125.5% | 0.00% | -66.7% |
| Q3 2021 | $326,000 | -40.4% | 5,500 | -12.7% | 0.00% | -40.0% |
| Q2 2021 | $547,000 | +128.9% | 6,300 | +117.2% | 0.01% | +150.0% |
| Q1 2021 | $239,000 | – | 2,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |